GENEQUANTUM HEALTHCARE
GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company that focuses on the research and development of innovative Bio-therapeutics. GeneQuantum was founded in August 2013 at Suzhou Industrial Park, and has built-up a world-class bio-conjugation technology platform, focusing on developing series of next generation anti-tumor Antibody-Drug-Conjugates (ADCs) with best-in-class potential. Securing this round of financing will significantly promote the development of current ADC candidates towards IND filling in both US and China, meanwhile further expanding the company's product pipeline.
GENEQUANTUM HEALTHCARE
Industry:
Health Care Personal Health Therapeutics
Founded:
2013-08-01
Address:
Beijing, Beijing, China
Country:
China
Total Employee:
1+
Status:
Active
Total Funding:
20.58 M USD
Current Employees Featured
Founder
Investors List
PICC Capital Investment Management
PICC Capital Investment Management investment in Series C - GeneQuantum Healthcare
China Life Private Equity Investment
China Life Private Equity Investment investment in Series C - GeneQuantum Healthcare
Suzhou Industrial Park Assets Management
Suzhou Industrial Park Assets Management investment in Series C - GeneQuantum Healthcare
TF Capital
TF Capital investment in Series B - GeneQuantum Healthcare
Huagai Capital
Huagai Capital investment in Series B - GeneQuantum Healthcare
Beijing Changping Technology Innodevelop Group
Beijing Changping Technology Innodevelop Group investment in Series B - GeneQuantum Healthcare
Hofan Venture
Hofan Venture investment in Series B - GeneQuantum Healthcare
Oriza Seed Capital (Oriza Yuandian)
Oriza Seed Capital (Oriza Yuandian) investment in Series B - GeneQuantum Healthcare
TF Capital
TF Capital investment in Series A - GeneQuantum Healthcare
Oriza Seed Capital (Oriza Yuandian)
Oriza Seed Capital (Oriza Yuandian) investment in Series A - GeneQuantum Healthcare
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-30 | GeneQuantum announces Dr. Yi Xia as Senior Vice President of Statistics and Data Science |
More informations about "GeneQuantum Healthcare" on Search Engine
GeneQuantum
ABOUT US. INNOVATIVE ECOSYSTEM BUILDER IN THE FIELD OF BIOCONJUGATE THERAPEUTICS. To drive impactful advances in global healthcare through pioneering and disruptive site-specific bioconjugation technologies that empower the next generation …See details»
ABOUT US_GeneQuantum
Genequantum healthcare (SUZHOU) CO., LTD. GeneQuantum, headquartered in China, is a global leader in the ADC field, distinguished for its advancement of enzymatic site-specific conjugation technologies.See details»
PIPELINE_GeneQuantum
GQ1011 is a first-in-class ADC targeting FGFR3, developed through a collaboration between Genequantum and Aimed Bio, a biotech company based in Korea. GQ1011 leverages Genequantum's iLDC technology, features a cleavable "open-ring" linker, and incorporates a novel Topoisomerase I inhibitor. GQ1011 has demonstrated potent anti …See details»
GeneQuantum Healthcare - Crunchbase Company Profile
GeneQuantum Healthcare is a high-tech company that focuses on the research and development of innovative Bio-therapeutics. Beijing, Beijing, China. 51-100. Series C. Private. www.genequantum.com/ 28,165. Highlights. Total Funding Amount. Unlock for free. Employee Profiles 2. Investors 8. Similar Companies 9. Company Insights.See details»
GeneQuantum and BioMap establish a strategic collaboration to …
SUZHOU, China, Dec. 17, 2023 /PRNewswire/ -- Recently, GeneQuantum Healthcare (GQ), a global leader in ADC new drug development focused on innovative bioconjugation technologies, and BioMap, a...See details»
World's first iLDC enabling ADC drug receives IND clearance by …
Jun 11, 2020 GeneQuantum Healthcare (Suzhou) Co., Ltd. is a privately held, innovative high-tech company dedicated to the development of First-in-Class and Best-in-Class novel biotherapeutics. Our vision is...See details»
GeneQuantum and WuXi XDC Entered into Strategic …
SUZHOU, China, Dec. 26, 2022 /PRNewswire/ -- GeneQuantum Healthcare (GQ), a global innovative biotechnology company dedicated to the development of the next generation...See details»
GeneQuantum Healthcare Company Profile 2024: Valuation, …
Description. Developer of bioconjugation drugs. The company's technology uses a ligase dependent conjugation platform that has opened a drastically enlarged therapeutic window, enabling researchers to focus on developing series of anti-tumor Antibody-Drug-Conjugates (ADCs). Contact Information. Website. www.genequantum.com. Ownership Status.See details»
GeneQuantum Healthcare - Funding, Financials, Valuation
Highlights. Funding Rounds 3. Total Funding Amount. Unlock for free. Lead Investors 2. Investors 8. Funding. GeneQuantum Healthcare has raised a total of. CN¥140M. in funding over 3 rounds. Their latest funding was raised on May 18, 2021 from a Series C round. GeneQuantum Healthcare is funded by 8 investors.See details»
GENEQUANTUM HEALTHCARE: World's first …
Jun 12, 2020 FDA Approval. By Press release submission | Jun 12, 2020. GeneQuantum Healthcare issued the following announcement on June 11. GeneQuantum Healthcare (GQ) has recently received the US IND …See details»
Thousand Oaks Biologics and GeneQuantum Healthcare Signed …
May 22, 2023 GeneQuantum Healthcare is a pioneering global biopharmaceutical company dedicated to the development of ADCs using the enzymatic site-specific conjugation technology.See details»
GeneQuantum and WuXi XDC have entered into strategic …
SUZHOU, China, Dec. 26, 2022 /PRNewswire/ — GeneQuantum Healthcare (GQ), a global innovative biotechnology company dedicated to the development of the next generation bioconjugate drugs , and WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that they have entered into a …See details»
GeneQuantum Healthcare | CipherBio
Founded in 2013 at BioBay, Suzhou, GeneQuantum Healthcare Co., Ltd. is a global innovative biopharmaceutical company that develops new bioconjugation drugs with differentiated platforms to provide safer, more effective and affordable drugs and treatm ... Stage: Public. Total Funds Raised: $0.00. Funding Products Partners People News …See details»
GeneQuantum Healthcare - Contacts, Employees, Board …
GeneQuantum Healthcare is a high-tech company that focuses on the research and development of innovative Bio-therapeutics.See details»
Who We Are – PATH Foundation
The PATH Foundation is a philanthropic charitable foundation that supports Fauquier, Rappahannock and Culpeper counties. Since inception, we’ve invested more than $48,000,000 in our community through grants, programs and partnerships. Through these partnerships, we help provide resources to our community and organizations that serve it.See details»
Private health care 'top gun' to lead Santé Québec, making …
Apr 30, 2024 On Tuesday, Quebec Health Minister Christian Dubé announced that Geneviève Biron, former CEO of Biron Groupe Santé, would be taking the reins of Santé Quebec, the agency that will oversee day ...See details»
GeneQuantum and WuXi XDC have entered into strategic …
SUZHOU, Dec. 26, 2022 - GeneQuantum Healthcare (GQ), a global innovative biotechnology company dedicated to the development of the next generation bioconjugate drugs , and WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that they have entered into a …See details»
PATH Foundation | Non-Profit - Fauquier Chamber of Commerce
About Us. Formerly known as the Fauquier Health Foundation, the PATH Foundation is a charitable grantmaking organization focused on enhancing the health and vitality of Fauquier, Rappahannock and northern Culpeper Counties. Rep/Contact Info. Christy Connolly. Send an Email. Our Members Mean Business. Fauquier Chamber of Commerce.See details»
GeneQuantum Healthcare's Two Next Generation Bioconjugate …
May 16, 2022 GeneQuantum Healthcare (Suzhou) Co., Ltd. is a global biotechnology company dedicated to the development of innovative biotherapeutics. The company is focused on the development of next...See details»
World Health Organization Is Making a Massive Power Grab
2 days ago The World Health Organization wants the power to run the world. In three weeks, it will make its bid for global control. The World Health Assembly, the 194-member body governing that organization ...See details»